04/16/2024 7:00 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024 7:13 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/29/2024 3:30 PM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/07/2024 7:02 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/22/2024 7:00 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/17/2024 7:02 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2023 7:01 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/07/2023 3:30 PM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/26/2023 3:30 PM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2023 7:00 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2023 3:42 PM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2023 7:00 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/01/2023 3:30 PM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/02/2023 7:05 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2023 7:05 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/26/2023 7:03 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2023 7:09 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2023 7:02 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2023 7:03 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |